134 related articles for article (PubMed ID: 28797706)
1. Prioritisation of specialist health care services; not NICE, not easy but it can be done.
Anderson P; Webb P; Groves S
Health Policy; 2017 Sep; 121(9):978-985. PubMed ID: 28797706
[TBL] [Abstract][Full Text] [Related]
2. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
[TBL] [Abstract][Full Text] [Related]
3. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
4. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
[TBL] [Abstract][Full Text] [Related]
5. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
Angelis A; Montibeller G; Hochhauser D; Kanavos P
BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
[TBL] [Abstract][Full Text] [Related]
6. TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.
Castro Jaramillo HE; Goetghebeur M; Moreno-Mattar O
Int J Technol Assess Health Care; 2016 Jan; 32(4):307-314. PubMed ID: 27691990
[TBL] [Abstract][Full Text] [Related]
7. Reallocating resources: how should the National Institute for Health and Clinical Excellence guide disinvestment efforts in the National Health Service?
Pearson S; Littlejohns P
J Health Serv Res Policy; 2007 Jul; 12(3):160-5. PubMed ID: 17716419
[TBL] [Abstract][Full Text] [Related]
8. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA).
Wahlster P; Goetghebeur M; Kriza C; Niederländer C; Kolominsky-Rabas P;
BMC Health Serv Res; 2015 Jul; 15():262. PubMed ID: 26152122
[TBL] [Abstract][Full Text] [Related]
9. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N;
Value Health; 2016; 19(2):125-37. PubMed ID: 27021745
[TBL] [Abstract][Full Text] [Related]
10. Does NICE apply the rule of rescue in its approach to highly specialised technologies?
Charlton V
J Med Ethics; 2022 Feb; 48(2):118-125. PubMed ID: 33685978
[TBL] [Abstract][Full Text] [Related]
11. Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review.
Moreno-Calderón A; Tong TS; Thokala P
Pharmacoeconomics; 2020 Mar; 38(3):269-283. PubMed ID: 31820294
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of patient input in health technology assessments at NICE.
Livingstone H; Verdiel V; Crosbie H; Upadhyaya S; Harris K; Thomas L
Int J Technol Assess Health Care; 2021 Jan; 37():e33. PubMed ID: 33509314
[TBL] [Abstract][Full Text] [Related]
13. Making Good Decisions in Healthcare with Multi-Criteria Decision Analysis: The Use, Current Research and Future Development of MCDA.
Mühlbacher AC; Kaczynski A
Appl Health Econ Health Policy; 2016 Feb; 14(1):29-40. PubMed ID: 26519081
[TBL] [Abstract][Full Text] [Related]
14. Translational health economics: The key to accountable adoption of in vitro diagnostic technologies.
Price CP; Wolstenholme J; McGinley P; St John A
Health Serv Manage Res; 2018 Feb; 31(1):43-50. PubMed ID: 29084478
[TBL] [Abstract][Full Text] [Related]
15. 'Real-world' health care priority setting using explicit decision criteria: a systematic review of the literature.
Cromwell I; Peacock SJ; Mitton C
BMC Health Serv Res; 2015 Apr; 15():164. PubMed ID: 25927636
[TBL] [Abstract][Full Text] [Related]
16. Multiple criteria decision analysis for health technology assessment.
Thokala P; Duenas A
Value Health; 2012 Dec; 15(8):1172-81. PubMed ID: 23244821
[TBL] [Abstract][Full Text] [Related]
17. A national Programme Budgeting and Marginal Analysis (PBMA) of health improvement spending across Wales: disinvestment and reinvestment across the life course.
Edwards RT; Charles JM; Thomas S; Bishop J; Cohen D; Groves S; Humphreys C; Howson H; Bradley P;
BMC Public Health; 2014 Aug; 14():837. PubMed ID: 25118054
[TBL] [Abstract][Full Text] [Related]
18. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
19. Multicriteria decision analysis in health care decision in oncology: a systematic review.
Campolina AG; Suzumura EA; Hong QN; de Soárez PC
Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):365-380. PubMed ID: 34913775
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
